The results showed that NODAGA as a chelator for 68Ga-labeled synthesis of molecular probes provided the best tumor-to-organ ratio, and was the best chelator for 68Ga-labeled HER2 affibody, indicating excellent prospects for clinical application (81, 92, 93). Here, ERBB2 is linked to neoplasm.